针对癌症免疫治疗的腺素通路的纳米粒子
Kehua Jiang1, Jian Wu2, Qing Wang1
1Department of Urology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China. guxy0324@163.com.
Journal of materials chemistry. B
|June 7, 2024
概括
抑制腺路径提供了一个有前途的癌症免疫治疗方法. 纳米技术增强了腺路径抑制剂,改善了药物输送,减少了副作用,从而改善了癌症治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
背景情况:
- 癌症免疫疗法显示出潜力,但面临着有效性和患者反应等局限性.
- 腺路径调节瘤免疫力和生长,使其抑制成为癌症治疗的目标.
- 目前的腺途径抑制剂在半衰期,生物可用性和施用途径方面存在局限性.
研究的目的:
- 审查瘤免疫抑制中的腺素途径的机制.
- 讨论腺途径抑制剂的临床应用.
- 在癌症治疗中探索腺酶通路抑制剂的纳米输送系统.
主要方法:
- 关于癌症中腺路径机制的文献综述.
- 对腺路抑制剂的临床前和临床数据的分析.
- 检查纳米技术在药物输送中的应用.
主要成果:
- 抑制腺素通路是一种有效的癌症免疫疗法策略.
- 纳米输送系统改善了循环时间,生物分布和抑制剂的向.
- 与传统的药物相比,纳米药物可以减少毒性副作用.
结论:
- 氨酸途径抑制剂的纳米输送对推进癌症免疫治疗具有重大前景.
- 解决纳米传递当前的技术挑战对于临床翻译至关重要.
- 进一步的研究可以优化纳米药物开发,以改善患者的治疗结果.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159